Related references
Note: Only part of the references are listed.Can Human Embryonic Stem Cell-Derived Stromal Cells Serve a Starting Material for Myoblasts?
Yu Ando et al.
STEM CELLS INTERNATIONAL (2017)
Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease
Thomas Doetschman et al.
CIRCULATION RESEARCH (2017)
Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model
Mikael Hivelin et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2016)
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Christopher E. Nelson et al.
SCIENCE (2016)
Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs
Clementina Sitzia et al.
MOLECULAR THERAPY (2016)
Confirmation of donor-derived dystrophin in a duchenne muscular dystrophy patient allotransplanted with normal myoblasts
Daniel Skuk et al.
MUSCLE & NERVE (2016)
Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure
M. V. Pelatti et al.
STEM CELL REVIEWS AND REPORTS (2016)
Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal Muscle
Lindsey A. Muir et al.
STEM CELLS AND DEVELOPMENT (2016)
Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy
Jinhong Meng et al.
SCIENTIFIC REPORTS (2016)
Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure
M. V. Pelatti et al.
STEM CELL REVIEWS AND REPORTS (2016)
Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells
Ignazio Maggio et al.
SCIENTIFIC REPORTS (2016)
Recent advances in the management of Duchenne muscular dystrophy
Eugen-Matthias Strehle et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2015)
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy
Giulio Cossu et al.
EMBO MOLECULAR MEDICINE (2015)
Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients
Daniel Skuk et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice
Yu Zhang et al.
HUMAN MOLECULAR GENETICS (2015)
Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy
Jerome Chal et al.
NATURE BIOTECHNOLOGY (2015)
Isolation and Immortalization of Patient-derived Cell Lines from Muscle Biopsy for Disease Modeling
Jerome D. Robin et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Duchenne muscular dystrophy: current cell therapies
Dorota Sienkiewicz et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2015)
Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD
Maddalena Noviello et al.
MOLECULAR THERAPY (2014)
Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA
Chengzu Long et al.
SCIENCE (2014)
Human Adipose Tissue Derived Pericytes Increase Life Span in Utrntm1Ked Dmdmdx/J Mice
M. C. Valadares et al.
STEM CELL REVIEWS AND REPORTS (2014)
Engraftment potential of dermal fibroblasts following in vivo myogenic conversion in immunocompetent dystrophic skeletal muscle
Lindsey A. Muir et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy
Alessandra Govoni et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Application of Cell-Based Therapies in Facial Transplantation
Maria Siemionow et al.
ANNALS OF PLASTIC SURGERY (2012)
A Simplified Immune Suppression Scheme Leads to Persistent Micro-dystrophin Expression in Duchenne Muscular Dystrophy Dogs
Jin-Hong Shin et al.
HUMAN GENE THERAPY (2012)
Long-term Engraftment of Multipotent Mesenchymal Stromal Cells That Differentiate to Form Myogenic Cells in Dogs With Duchenne Muscular Dystrophy
Yuko Nitahara-Kasahara et al.
MOLECULAR THERAPY (2012)
Myoblasts Derived From Normal hESCs and Dystrophic hiPSCs Efficiently Fuse With Existing Muscle Fibers Following Transplantation
Sebastien Goudenege et al.
MOLECULAR THERAPY (2012)
Donor Satellite Cell Engraftment is Significantly Augmented When the Host Niche is Preserved and Endogenous Satellite Cells are Incapacitated
Luisa Boldrin et al.
STEM CELLS (2012)
Physiological Characterization of Muscle Strength With Variable Levels of Dystrophin Restoration in mdx Mice Following Local Antisense Therapy
Paul S. Sharp et al.
MOLECULAR THERAPY (2011)
Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy
Beniamino Palmieri et al.
PEDIATRIC TRANSPLANTATION (2010)
Long-Term Survival of Composite Hemiface/Mandible/Tongue Allografts Correlates With Multilineage Chimerism Development in the Lymphoid and Myeloid Compartments of Recipients
Yalcin Kulahci et al.
TRANSPLANTATION (2010)
Near-total human face transplantation for a severely disfigured patient in the USA
Maria Siemionow et al.
LANCET (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. (vol 8, pg 918, 2009)
M. Kinali et al.
LANCET NEUROLOGY (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali et al.
LANCET NEUROLOGY (2009)
Hematopoietic stem cell engraftment and seeding permits multi-lymphoid chimerism in vascularized bone marrow transplants
M. Siemionow et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
First test of a high-density injection protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up
Daniel Skuk et al.
NEUROMUSCULAR DISORDERS (2007)
Autologous transplantation of muscle-derived CD133(+) stem cells in Duchenne muscle patients
Y. Torrente et al.
CELL TRANSPLANTATION (2007)
Role of thymus in operational tolerance induction in limb allograft transplant model
Maria Siemionow et al.
TRANSPLANTATION (2006)
Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier
S. Ozmen et al.
TRANSPLANTATION PROCEEDINGS (2006)
Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants
M Siemionow et al.
TRANSPLANTATION (2005)
Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier
MZ Siemionow et al.
TRANSPLANTATION PROCEEDINGS (2005)
Donor-specific tolerance in fully major histocompatibility complex-mismatched limb allograft transplants under an anti-αβ T-cell receptor monoclonal antibody and cyclosporine A protocol
MZ Siemionow et al.
TRANSPLANTATION (2003)
Share Paper
